Clinical Trial Update: Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss [Phase 1, Phase 2]

View source ↗

Summary

The completed Phase 1/2 trial investigated the safety of autologous stem cell infusion in children with acquired sensorineural hearing loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sensorineural Hearing Loss

Drugs mentioned

• Autologous stem cell infusion

Snippet

Sponsor: James Baumgartner, MD | Conditions: Sensorineural Hearing Loss | Phase 1, Phase 2 | Status: COMPLETED